73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Some skin cancers may start in hair follicles

Some skin cancers may start in hair follicles

by NYU Langone HealthCredit: CC0 Public DomainSome of the most deadly skin cancers may start in stem cells that lend color to hair, and originate in hair follicles rather than in skin layers, a n

Some skin cancers may start in hair follicles

by NYU Langone HealthCredit: CC0 Public DomainSome of the most deadly skin cancers may start in stem cells that lend color to hair, and originate in hair follicles rather than in skin layers, a n
Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

by Impact Journals LLCFigure 1 (truncated): Idh2R140Q/NHD13 double transgenic mice develop EITP ALL resembling the human disease. Credit: 2022 Negi and AplanA new research perspective titled "A m

Team publishes new study on murine model for human early/immature T-cell precursor acute lymphoblastic leukemia

by Impact Journals LLCFigure 1 (truncated): Idh2R140Q/NHD13 double transgenic mice develop EITP ALL resembling the human disease. Credit: 2022 Negi and AplanA new research perspective titled "A m
Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q
Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e
Research uncovers alternate mechanism for producing key protein in metastatic prostate cancer

Research uncovers alternate mechanism for producing key protein in metastatic prostate cancer

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainLike the better-known prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA) is a biomarker that can tell physi

Research uncovers alternate mechanism for producing key protein in metastatic prostate cancer

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainLike the better-known prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA) is a biomarker that can tell physi
Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of
Multiple recurrent, repeat expansions found in human cancer genomes

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca
Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

by WileyMelanoma. Credit: Wikimedia Commons/National Cancer InstituteAlthough melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

by WileyMelanoma. Credit: Wikimedia Commons/National Cancer InstituteAlthough melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is
Breakthrough research makes cancer-fighting viral agent more effective

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio
Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2
Study finds racial disparities in culturally competent cancer care

Study finds racial disparities in culturally competent cancer care

by Dana-Farber Cancer InstituteBrandon A. Mahal, MD of Dana-Farber Cancer Institute, co-senior author of the study published inJAMA Oncology. Credit: Dana-Farber Cancer InstituteMany non-wh

Study finds racial disparities in culturally competent cancer care

by Dana-Farber Cancer InstituteBrandon A. Mahal, MD of Dana-Farber Cancer Institute, co-senior author of the study published inJAMA Oncology. Credit: Dana-Farber Cancer InstituteMany non-wh
Prostate cancer drug given initial 'no' for NHS in England

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In